ACI
UTHR icon

Advance Capital I’s United Therapeutics UTHR Stock Holding History

Advance Capital I’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-17,600
Closed -$2.26M – 202
2014
Q3 		$2.26M Hold
17,600
– – 1.1% 9
2014
Q2 		$1.56M Buy
+17,600
New +$1.69M 0.73% 82
2014
Q1 		– Sell
-6,600
Closed -$746K – 286
2013
Q4 		$746K Buy
+6,600
New +$595K 0.36% 103
2013
Q3 		– Sell
-4,600
Closed -$303K – 372
2013
Q2 		$303K Buy
+4,600
New +$296K 0.15% 272

Other funds holding UTHR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Advance Capital I's UTHR Position: Q4 2014 in Review

Advance Capital I sold out of United Therapeutics (UTHR) in Q4 2014, closing a stake of 17,600 shares — an estimated $2.26M sold.

Advance Capital I first reported a position in UTHR in Q2 2013 and held it in 4 quarters. The position peaked at $2.26M in Q3 2014. 334 funds tracked by Wall St. Rank hold UTHR as of Q4 2014.

  • Advance Capital I reported no remaining United Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Advance Capital I sold 17,600 United Therapeutics shares in Q4 2014, an estimated $2.26M.
  • Advance Capital I first reported a position in United Therapeutics in Q2 2013 and held it in 4 quarters.
  • Advance Capital I's United Therapeutics position peaked at $2.26M in Q3 2014.
  • 334 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2014.

Based on Advance Capital I's 13F filing for Q4 2014, filed 5 Feb 2015.